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The acidic dipeptide N-acetylaspartylglutamate (NAAG), which satisfies many of the criteria for a 
neurotransmitter, was identified immunohistochemically within two human retinae. We observed 
NAAG immunoreactivity in retinal ganglion cells, their dendrites in the inner plexiform layer, and 
their axons in the optic nerve fiber layer. The vast majority of ganglion cells were stained, including 
displaced ganglion cells, ganglion cells of different sizes, and those whose dendrites arborized in the 
inner and outer sublaminae of the inner plexiform layer, that is, presumed On- and Off- cells. The 
sizes of labeled and unlabeled cells in the ganglion cell layer, as measured in counterstained 
material, suggest hat the unlabeled cells consist primarily or only of displaced amacrine cells. We 
also saw immunoreactivity in small cells along the inner margin of the inner nuclear layer, 
presumably amacrine cells, and in small cells with little cytoplasm in the inner plexiform and 
ganglion cell layers, presumably displaced amacrine cells. These results are consistent with a role 
for NAAG in the transmission of visual information from the retina to the rest of the brain. Further, 
they are similar to those reported previously in rat, cat and monkey, thus demonstrating the 
relevance of previous studies to humans. 
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INTRODUCTION 
The neurotransmitters used by mammalian retinal gang- 
lion cells remain unknown, although receptors for the 
acidic amino acids, aspartate and glutamate, appear to be 
involved in retinogeniculate (Kemp & Sillito, 1982; 
Crunelli, Kelly, Leresche & Pirchio, 1987; Sillito, 
Murphy & Salt, 1990; Sillito, Murphy, Salt & Moody, 
1990), retinocollicular (Roberts, Eaton & Salt, 1991) and 
retinohypothalamic (Cahill & Menaker, 1989; Takeuchi, 
Takashima, Katoh, Nishikawa & Takahashi, 1991) 
transmission. However, although glutamate immuno- 
reactivity has been localized in retinal ganglion cells and 
their terminals (Montero & Wenthold, 1989; Montero, 
1990, 1994; Davanger, Ottersen & Storm-Mathisen, 
1991; Nunes Cardozo, Buijs & Van der Want, 1991; 
Crooks & Kolb, 1992), neither glutamate nor aspartate is
released from those terminals in a calcium-dependent 
fashion (Sandberg & Corazzi, 1983; Tsai, Forloni, 
Robinson, Stauch & Coyle, 1988; Tsai, Stauch, Vornov, 
Deshpande & Coyle, 1990). This suggests that retinal 
* Neurobiology Research Center and Department of Biological 
Sciences, State University of New York, Albany, NY 12222, 
U.S.A. 
t To whom all correspondence should be addressed [Tel. (518) 442- 
4317; Fax 2518) 442-4767; Email tieman@albany.edu]. 
ganglion cells may use as their neurotransmitter not 
aspartate or glutamate, but some other endogenous 
glutamate receptor agonist. 
N-acetylaspartylglutamate (NAAG) is an endogenous 
brain peptide (Curatolo, D'Arcangelo & Lino, 1965; 
Miyamoto, Kakimoto & Sano, 1966; Koller, Zaczek & 
Coyle, 1984) that activates an acidic amino acid receptor. 
Most studies uggest that NAAG acts preferentially at the 
N-methyl-D-aspartate (NMDA) receptor (Westbrook, 
Mayer, Namboodiri & Neale, 1986; Sekiguchi, Okamoto 
& Sakai, 1987; Trombley & Westbrook, 1990; Sekiguchi, 
Wada & Wenthold, 1992; Koenig, Rothbard, DeCoster & 
Meyerhoff, 1994; Valivullah, Lancaster, Sweetnam & 
Neale, 1994), but there are several reports of activity at 
other types of glutamate r ceptor (JoWls, Van Veldhuizen, 
Urban & DeKloet, 1987; GaUi, Godeheu, Artaud, Desce, 
Pittaluga, Barbeito, Glowinski & Chframy, 1991; 
Wroblewska, Wroblewski, Saab & Neale, 1993). 
Although its role in nervous ystem function has yet to 
be determined, several ines of evidence suggest hat 
NAAG may be a neurotransmitter (reviewed by Blakely 
& Coyle, 1988). Most importantly, NAAG has been 
localized immunocytochemically within synaptic vesi- 
cles (Williamson & Neale, 1988b), and it is released in a 
calcium-dependent manner by depolarization (Pittaluga, 
Barbeito, Serval, Godeheu, Artaud, Glowinski & Chfr- 
amy, 1988; Tsai et al., 1988, 1990; Williamson & Neale, 
1988a; Zollinger, Amsler, Do, Streit & Cufnod, 1988; 
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Williamson, Eagles, Brady, Moffett, Namboodiri & 
Neale, 1991). 
Physiological support for NAAG's role as an excita- 
tory neurotransmitter is mixed. Despite the many positive 
reports cited above, NAAG was reported to be ineffective 
in activating cells in the piriform cortex (Whittemore &
Koerner, 1989) or ventrobasal nucleus (Henderson & 
Salt, 1988) of the rat or the lateral geniculate nucleus 
(LGN) of the cat (Jones & Sillito, 1992). However, we 
have found that NAAG can excite cells in slices of rat 
LGN (Tieman, Hori, Carpenter & Tieman, 1991), 
consistent with excitatory effects in another etinal target, 
the suprachiasmatic nucleus (Bos & Mirmiran, 1993). 
Such physiological studies are not possible in human, 
but we can examine the distribution of NAAG in human 
tissue and compare it to that in other species. These 
comparisons can be used in part to evaluate the relevance 
to human of physiological studies performed in other 
species. We have previously identified NAAG-like 
immunoreactivity in retinal ganglion cells and amacrine 
cells of cat (Tieman, Cangro & Neale, 1987) and monkey 
(Tieman, Neale & Tieman, 1991). We now report a 
similar distribution in human retina. Brief reports of some 
of these results have appeared elsewhere (Tieman & 
Tieman, 1988; Tieman, Butler & Neale, 1988). 
METHODS 
Antisera 
The antisera were prepared as previously described 
(Anderson, Monaghan, Cangro, Namboodiri, Neale & 
Cotman, 1986; Anderson, Borja, Cotman, Moffett, 
Namboodiri & Neale, 1987; Cangro, Namboodiri, Sklar, 
Corigliano-Murphy & Neale, 1987). Briefly, NAAG was 
synthesized, purified and coupled to thyroglobulin with 
carbodiimide, and the conjugate used to immunize two 
rabbits. The antisera have been tested by ELISA and 
immunoblotting and have shown minimal cross-reactiv- 
ity with NAAG-related molecules including glutamate, 
aspartate, ~-glutamylglutamate, spartylglutamate nd N- 
acetylaspartate (Anderson et al., 1986; Cangro et al., 
1987; Kowalski, Cassidy, Namboodiri & Neale, 1987). 
Affinity-purified antiserum was prepared as described 
previously (Moffett, Cassidy & Namboodiri, 1989). The 
affinity-purified antiserum shows even less cross-reac- 
tivity with NAAG-related molecules (Tieman, Moffett & 
Irtenkauf, 1991a, b). 
Subjects and histology 
We studied the pattern of NAAG immunoreactivity in 
the retinae of two caucasian males, aged 70 yr (H-l) and 
51 yr (H-2). The eyes, which were obtained from the 
Lions Eye Bank at the Albany Medical College, were 
placed in cold (4°C) fixative 24 hr (H-l) or 8.5 hr (H-2) 
after death, where they remained for 2 days (H-l) or 4 
days (H-2). The fronts of the eyes were removed to 
improve retinal access to the fixative, which was a 
mixture of 4% paraforrnaldehyde and 4% 1-ethyl-3-(3- 
dimethylaminopropyl)-carbodiimide (carbodiimide, Sig- 
ma E7750) in 0.1 M phosphate buffer (pH 7.4). Fixation 
with aldehydes alone does not efficiently retain NAAG 
(Anderson et al., 1986) because of the peptide's mall 
size and acetylated amine group. Carbodiimide is 
effective because it promotes the formation of peptide 
bonds between NAAG's free carboxyl groups and free 
amine groups in the tissue. 
The eyes were then rinsed overnight in phosphate 
buffer and cryoprotected in buffered sucrose. Pieces of 
retina were then frozen, sectioned at 30/~m into 
phosphate buffer and stored at 4°C. Some pieces of 
retina were sectioned with a cryostat, mounted irectly 
onto gelatinized slides, and stored at -20~C. 
lmmunocytochemistry 
Sections were stained on the slide or free-floating as 
described previously (Tieman et al., 1987, 1991b). 
Briefly, sections were incubated overnight at 4°C in 
NAAG antiserum (bleed 9 from rabbit IX or bleed 8 or 10 
from rabbit X) diluted 1:4000 to 1:16,000 or affinity- 
purified NAAG antiserum diluted 1 : 1500 to 1 : 2500, 
incubated in biotinylated goat anti-rabbit (Vector) at 
1:200 or 1:800, exposed to avidin-biotin-peroxidase 
complex (Vector), and reacted in diaminobenzidine and 
H~O2. To minimize handling, free-floating sections were 
transferred from solution to solution in tissue carriers 
constructed of small hollow plastic cylinders with silk 
screen glued to the bottom. In some cases, the staining 
was enhanced with cobalt chloride (Adams, 1981). 
Selected sections were counterstained with thionin. 
Controls 
The specificity of the stt, ining was demonstrated bythe 
following: first, the pattern of staining was similar with 
antisera from two different rabbits and with the affinity- 
purified antiserum. Second, we substituted normal rabbit 
serum for the anti-NAAG sera, and obtained no staining 
or only very faint staining. Third, we were able to block 
staining by pre-incubating the anti-NAAG sera with 
NAAG conjugated to bovine serum albumen (NAAG- 
BSA) at 1.5/zg/ml. Concentrations as low as 150 ng/ml 
diminished, but did not block the staining. In contrast, we 
were unable to block staining with BSA conjugated to 
either N-acetylaspartate or aspartylglutamate t concen- 
trations of 500/tg/ml, the highest concentrations tested. 
These results are consistent with earlier blocking data 
using these antisera (Anderson et al., 1986, 1987; Cangro 
et al., 1987; Tieman et aL, 1987, 1991b), and further 
demonstrate heir specificity. We did not test blocking 
with glutamate or aspartate conjugated to BSA because 
previous studies found no cross-reactivity with either 
(Cangro et al., 1987; Kowalski et al., 1987; Tieman et al., 
1991a). 
Cell measurements 
To determine the relative sizes of labeled and 
unlabeled cells in the retinal ganglion cell layer, we 
measured the areas of both types of cells in a portion of 
one section of counterstained retina from H-2. Cells were 
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drawn at 1250 x and entered irectly into a computer 
with the aid of a mouse-controlled cursor and a drawing 
tube positioned so that the image displayed on a 
computer monitor was superimposed on the image of 
the cell. For each cell the experimenter indicated whether 
the cell was labeled or unlabeled (i.e. stained only by 
thionin). The computer then calculated the area of each 
cell and tabulated the results. 
RESULTS 
The results for the two retinae were essentially similar, 
although most of the illustrations were taken from that of 
H-2, for which the preservation was superior. The 
heaviest staining was in the retinal ganglion cells and 
their processes; amacrine cells were more lightly stained. 
The perikarya of the retinal ganglion cells were 
stained, as were their dendrites in the inner plexiform 
layer and their axons in the optic nerve fiber layer. In 
regions where the optic nerve fiber layer was thick, the 
fixation of the other layers was relatively poor, as if the 
fixative had failed to penetrate well. For this reason, all of 
the illustrations were taken from sections of retina where 
the optic nerve fiber layer was relatively thin. Figure I(A) 
shows a tangential section of peripheral retina. Scattered 
ganglion cells of different sizes were labeled (large 
arrows), as were retinal ganglion cell axons (small 
arrows). These were somewhat irregular and broken up, 
as if they were starting to degenerate. There was also 
some staining throughout the neuropil of the inner 
plexiform layer (IPL). Figure I(B) shows that all or 
nearly all of the retinal ganglion cells in parafoveal retina 
were labeled, including cells throughout the depth of the 
ganglion cell layer, suggesting, by analogy with the 
monkey, that all major classes of ganglion cells contain 
NAAG (i.e., M, P, midbrain projecting, On- and Off-), 
since these various types occur at different depths of the 
ganglion cell layer (Perry & Silveira, 1988). 
The dendrites of some of the retinal ganglion cells 
could be followed for some distance into the inner 
plexiform layer. Cells with dendrites arborizing in the 
inner sublamina of the inner plexiform layer were labeled 
[Fig. I(D, E)], as were those with dendrites arborizing in 
the outer sublamina [Fig. I(C, D)]; that is, both On-center 
and Off-center cells (Nelson, Famiglietti & Kolb, 1978) 
were labeled. Labeled ganglion cells included both large 
and small cells [Fig. I(A, D-F)], that is, both M and P 
cells [terminology ofShapley and Perry (1986)]. We also 
saw numerous large, stained cells in the inner nuclear 
layer with relatively large amounts of cytoplasm 
[indicated by solid triangles in Fig. I(B, E, F)]. Based 
on their size and morphology, we believe that these are 
displaced ganglion cells. The cell indicated in I(B) is 
much smaller than those in I(E, F), but I(B) is from the 
parafovea, whereas I(E, F) are from the periphery 
(eccentricity about 15 mm), and ganglion cells are much 
smaller in central than peripheral retina. At all eccentri- 
cities, the cells we are calling displaced ganglion cells 
fall within the size range of the ganglion cells in the 
ganglion cell layer. In summary, the size, distribution and 
dendritic branching of labeled cells in the ganglion cell 
and inner nuclear layers suggest that all major classes of 
ganglion cells in the human retina contain NAAG. 
In counterstained sections, those cells in the retinal 
ganglion cell layer that were not immunoreactive for 
NAAG were small and had relatively little cytoplasm, 
morphology characteristic of displaced amacrine cells 
(Curcio & Allen, 1990). Most of the stained cells were 
larger, had more cytoplasm, and often had eccentric 
nuclei, morphology typical of ganglion cells (Curcio & 
Allen, 1990). We measured the areas of 410 cells in the 
retinal ganglion cell layer from one counterstained 
section from H-2 at an eccentricity of 15-21 mm. Of 
these, slightly more than half (218) were labeled. 
However, we may have underestimated the number of 
unlabeled cells, because itwas difficult o see through the 
immunolabeled processes of other cells, those cells that 
were only lightly stained by the thionin. The distribution 
of cell sizes is shown in Fig. 2. The unlabeled cells (open 
bars) were smaller, on average, than the labeled cells 
(solid bars), although the range of sizes for the unlabeled 
cells was within that for the labeled cells. This suggests 
that the population of unlabeled cells consists of 
displaced amacrine cells, although it may include a few 
small ganglion cells. 
Many other stained cells were located in the inner 
nuclear layer along the inner margin [indicated by open 
triangles in Fig. I(A, C-F)]; these are presumably 
amacrine cells. In general, these were not as darkly 
stained as the ganglion cells. They were smaller, with 
only thin rims of cytoplasm. The difference between 
these and the ones we are calling displaced ganglion cells 
can be seen in Figure I(E, F). The frequency of labeled 
amacrine cells was greater in peripheral than in central 
retina. Some stained cells in the inner plexiform and 
ganglion cell layers had morphologies suggesting that 
they are displaced amacrine cells (Curcio & Allen, 
1990). That is, they were among the smallest cells in the 
ganglion cell layer at that eccentricity, had only thin rims 
of cytoplasm, and were often within or near the inner 
plexiform layer [open arrow, Fig. I(A, C)]. 
DISCUSSION 
We observed NAAG-like immunoreactivity n retinal 
ganglion cells and amacrine cells. NAAG-like immuno- 
reactivity has previously been identified in both ganglion 
cells and amacrine cells of turtle (Eldred, Coyle & 
Joneckis, 1992), chick (Williamson et al., 1991), cat 
(Tieman et al., 1987) and monkey (Tieman et al., 1991b) 
and in amacrine cells of frog (Kowalski et al., 1987). 
NAAG-immunoreactive amacrine cells in cat and 
monkey include displaced amacrine cells (Tieman & 
Fry, 1989; Tieman et al., 1991b), as they did here. NAAG 
immunoreactive amacrine cells are least frequent in cat 
and most frequent in frog and chick. In those species for 
which immunoreactivity is present in both amacrine cells 
and ganglion cells, the staining in the amacrine cells 
tends to be less intense (Tieman et al., 1987, 1991b; 
Williamson et al., 1991), as it was here. Nevertheless, 
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FIGURE 1. Pattern of NAAG labeling in human retina: (A) tangential section of peripheral retina, showing label in retinal 
ganglion cells (large arrows) and their axons (small arrows). There is label throughout the inner plexiform layer (IPL). The open 
triangle indicates a labeled amacrine cell in the inner nuclear layer (INL), and the open arrow indicates a displaced amacrine cell 
in the inner plexiform layer. H-2, antiserum X-10 at 1 : 4000, cobalt-intensified. Scale bar, 20/~m; (B) transverse s ction through 
parafoveal retina. Labeled cells are distributed throughout the ganglion cell layer (GCL). The solid triangle indicates what is 
probably adisplaced ganglion cell in the inner nuclear layer. H-l, antiserum X-8 at 1 : 16,000~ Scale bar, 50 ~m; (C) small Off- 
cell, which sends a large dendrite into the outer portion of the inner plexiform layer (arrowheads). The open triangle indicates a
labeled amacrine cell in the inner nuclear layer, and the open arrow indicates a displaced amacrine cell in the inner plexiform 
layer. Eccentricity about 8 mm. H-2, antiserum X-10 at 1:4000, cobalt-intensified. Scale bar, 20 vm; (D) small Off-cell (left) 
and large On-cell (right). Open triangles indicate labeled amacrine cells in the inner nuclear layer. Eccentricity, about 11 mm. 
H-2, antiserum X-10 at 1:4000, cobalt-intensified. Scale bar, 20 #m, applies to (E) and (F) as well; (E) displaced ganglion cell 
immunoreactive forNAAG (solid triangle). Open triangle indicates labeled amacrine cell for comparison. Two small ganglion 
cells in the ganglion cell layer are also labeled, as are both the inner and outer plexiform layers; and (F) adjacent section of retina 
to that shown in (E). Both large and small ganglion cells in the ganglion cell layer are labeled in addition to the displaced 
ganglion cell (solid triangle) and amacrine ceils (open triangles). The small arrowheads point to a dendrite of a large On-cell 
arborizing in the inner half of the inner nuclear layer. Eccentricity, about 15 mm. H-2, antiserum IX-9 at 1:8000. 
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FIGURE 2. Size distributions of labeled (solid bars) and unlabeled 
(open bars) cells in the retinal ganglion cell layer at an eccentricity of 
15-21 mm. The section from which these data were taken was from H- 
2, stained with antiserum X-10 at 1:4000, cobalt-intensified and 
counterstained with thionin. 
NAAG is released from these cells in a calcium- 
dependent manner (Williamson et al., 1991). 
NAAG-like immunoreactivity was observed in the vast 
majority of retinal ganglion cells, including both large 
and small cells, putative On-cells, Off-cells and displaced 
ganglion cells. Further, our analysis of cell sizes in a 
counterstained section is consistent with the idea that all 
ganglion cells contain NAAG. First, the proportion of 
labeled cells is what would be expected if all ganglion 
cells and a few displaced amacrine cells contain NAAG, 
since 50% or more of the neurons in the retinal ganglion 
cell layer are displaced amacrine cells, ranging from <3% 
in central retina to 70% at the extreme periphery (Curcio 
& Allen, 1990). Second, the distribution of cell sizes is 
consistent with this suggestion, since the sizes of 
unlabeled cells fell at the small end of that for the 
labeled cells. Finally, the morphology of the unlabeled 
cells resembled that of displaced amacrine cells (Curcio 
& Allen, 1990). The localization of NAAG in most or all 
retinal ganglion cells, including representatives of all of 
the major classes, is similar to what we found in the cat 
(Tieman et al., 1987) and monkey (Tieman et al., 1991b). 
The similarity of the results reported here to those in 
other mammals (Anderson et al., 1987; Tieman et al., 
1987, 1991b) suggests that results from functional studies 
of NAAG in other species can reasonably be extrapolated 
to human. 
NAAG immunoreactivity has been observed in the 
neuropil of the retinal target areas in rat (Anderson et aL, 
1987; Moffett et al., 1991), cat (Tieman et al., 1987, 
1991a) and monkey (Tieman et al., 1991a). The blocking 
data for the retinal ganglion cells in this and previous 
experiments uggest that the antibodies are in fact 
recognizing NAAG. Further, the presence of NAAG in 
retinal target areas (LGN and superior colliculus) of the 
rat and monkey has been confirmed using high 
performance liquid chromatography (HPLC) (Anderson 
et al., 1987; Moffett et al., 1991; Molinar-Rode & Pasik, 
1992). Unilateral eye removal in rat decreases NAAG 
levels in contralateral LGN and superior colliculus, as 
assayed both with HPLC and with immunohistochem- 
istry (Anderson et al., 1987; Moffett et al., 1991). 
Similarly, removal of one eye in the cat leads to 
decreased NAAG immunoreactivity in ipsilateral geni- 
culate layer A1 and contralateral superior colliculus and 
geniculate layer A (Tieman et al., 1991a) and lesions of 
the optic tract in monkey decrease NAAG levels in 
ipsilateral LGN, as determined by HPLC (Molinar-Rode 
& Pasik, 1992). Further, the decreases in NAAG 
produced by optic deafferentation are greater than 
those observed for aspartate or glutamate (Williamson, 
Moffett, Garrison, Murphy, Palkovits, Neale & Namboo- 
diri, 1989; Molinar-Rode & Pasik, 1992). Finally, NAAG 
is released in a calcium-dependent manner in chick optic 
tectum (Williamson et al., 1991) and rat superior 
colliculus (Tsai et al., 1990) upon stimulation of the 
optic nerve fibers. These results uggest that NAAG may 
participate in chemical neurotransmission from retinal 
ganglion cells. 
As noted in the Introduction, most or all mammalian 
[including human (Davanger et al., 1991; Crooks & 
Kolb, 1992)] retinal ganglion cells and their terminals 
also contain glutamate. Since both NAAG and glutamate 
are present, heir respective roles are not clear. Glutamate 
could be a synthetic precursor or a breakdown product of 
NAAG. Similarly, NAAG could provide a discrete 
neuronal source for a neurotransmitter pool of glutamate. 
Several ines of evidence favor NAAG over aspartate or 
glutamate as the transmitter for retinal ganglion cells, 
discussed in Tieman et al. (1991b) [but see Montero 
(1994)]. Of the evidence favoring NAAG, the most 
critical is that showing calcium-dependent release of 
NAAG, but not aspartate or glutamate, from retinal 
terminals (Tsai et al., 1988, 1990; Williamson et al., 
1991). On the other hand, NAAG's ability to excite 
neurons in retinal targets is controversial (Tieman et al., 
1991; Jones & Sillito, 1992; Bos & Mirmiran, 1993). It is 
possible that NAAG is released, but is immediately 
hydrolyzed to N-acetylaspartate and glutamate, and that 
glutamate is the substance that excites the postsynaptic 
cell. However, several recent studies have suggested that 
NAAG can act directly, and not just by means of the 
hydrolyzed glutamate (Galli et al., 1991; Koenig et al., 
1994; Valivullah et al., 1994). Additional studies 
involving physiology and pharmacology will be needed 
to unravel the relative contributions of glutamate and 
NAAG to retinofugal transmission. 
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